Semaphore Solutions, creator of Labbit and leader in laboratory informatics solutions, announced a bold, expanded vision for its laboratory informatics platform today. This vision positions Labbit not ...

REGENXBIO Inc. (Nasdaq: RGNX) today announced new interim biomarker data from the Phase I/II portion of the AFFINITY DUCHENNE® trial of RGX-202 for the treatment of Duchenne muscular dystrophy will be ...